Acceptability of Low Levels of Genotoxic Impurities in New Drug Substances: Case Reports

By Bernard Leblanc  

International Journal of Pharmaceutical Medicine, Vol. 18, Iss. 4, 2004-01 ,pp. : 215-220

Adis International

Access to resources Recommend Favorite

Assessment and Acceptance of Thresholds of Genotoxic Impurities in New Drug Substances: A Regulatory Perspective

By Peter Kasper  

International Journal of Pharmaceutical Medicine, Vol. 18, Iss. 4, 2004-01 ,pp. : 209-214

Adis International

Access to resources Recommend Favorite

Acceptability of Low Levels of Genotoxic Impurities in New Drug Substances: Conclusions of the Drug Information Association (DIA)/European Medicines Agency (EMEA) Workshop, October 27-28, 2003 in London, UK

By Peter Kasper  

International Journal of Pharmaceutical Medicine, Vol. 18, Iss. 4, 2004-01 ,pp. : 221-223

Adis International

Access to resources Recommend Favorite

Probabilistic Approach to the Establishment of Maximal Content Limits of Impurities in Drug Formulations: The Case of Parenteral Diphenylhydantoic Acid

By Manca D.   Walker R.M.   Krishna G.   Graziano M.J.   Kropko M.L.  

Regulatory Toxicology and Pharmacology, Vol. 29, Iss. 1, 1999-02 ,pp. : 1-14

Academic Press

Access to resources Recommend Favorite

Nanocarrier based Antiretroviral Drug Delivery Approaches

By  

Pharmaceutical Nanotechnology, Vol. 1, Iss. 4, 2013-11 ,pp. : 259-268

Bentham Science Publishers

Access to resources Recommend Favorite